24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
07/05/2014
The new Hewlett-Packard world development center for 3D printers will be in Barcelona
28/04/2014
Loss of memory reversed in Alzheimer's mice models
25/04/2014
More than 30 companies attended the ALBA industry workshop
15/04/2014
European Commission names Barcelona first European Capital of Innovation
11/04/2014
Visit of the Spanish State Secretary for research to the Barcelona Synchrotron Park (BSP)
02/04/2014
High-precision molding in the PTV